HB 1426 — Maryland
Clinical Research Pharmacies and Clinical Trials - Permits and Ownership
No summary was supplied with the source record. Read the full text below.
Latest action: Referred Rules · Apr 13, 2026
Status label is derived from the recorded actions. The full text below is the record.
Updated Apr 16, 2026
Timeline
First Reading Health
Feb 13, 2026 · House of Delegates
Hearing 3/05 at 1:00 p.m.
Feb 13, 2026 · House of Delegates
Favorable with Amendments Report by Health
Apr 11, 2026 · House of Delegates
Favorable with Amendments {
Apr 13, 2026 · House of Delegates
Second Reading Passed with Amendments
Apr 13, 2026 · House of Delegates
Third Reading Passed
Apr 13, 2026 · House of Delegates
Referred Rules
Apr 13, 2026 · Senate
Sponsored by Jared Solomon, Heather Bagnall Tudball, Bonnie Cullison, Pam Guzzone, Terri Hill, Tom Hutchinson, Steve Johnson, Aaron Kaufman, Nic Kipke, Lesley Lopez, Teresa Reilly, Sandy Rosenberg, Kim Ross, Deni Taveras, Jennifer White Holland, Teresa Woorman, Martinez
House of Delegates vote — 129–5
On Third Reading · Mar 31, 2026 · result: pass
129 yea · 5 nay · 7 absent, excused, abstain or not voting
Official records. Maryland legislators, bills and roll-call votes from the Maryland General Assembly, imported through Open States on Oct 27, 2026 (trial import — not the full session). Accuracy review against the official site is still under way. Campaign-finance records for Maryland are not imported yet.